Linda Peckel

A multidisciplinary team of scleroderma specialists developed a framework for a comprehensive and sustainable approach to treating scleroderma.

Rheumatologists and pulmonologists provide differing perspectives on risk factors, disease assessment, and treatment strategies for patients with rheumatoid arthritis-associated interstitial lung disease.

Five phenotypic asthma clusters were identified by the Severe Asthma Research Program that differentiated phenotypes by age of onset, allergen sensitization, lung function, medications, healthcare utilization, and comorbidities.

Investigators are identifying the multifaceted etiology of allergic diseases, including asthma, as a way to develop novel biological agents that are being designed to influence particular segments of pathogenic pathways.

Clinical trial research is set to comply with a new code of ethics in 2018.

Pulmonary and thoracic symptoms often coincide with initial presentation of connective tissue disease.

While the newest high-valent PCV10 and PCV13 vaccines are effective in preventing IPD caused by the serotypes within the vaccines, breakthrough patterns of conversion to non-PCV13 serotypes are emerging.

A new algorithm developed by the National Institute for Health and Care Excellence was not useful for diagnosing asthma in children and adolescents.

Inhaled corticosteroids for COPD does not increase the risk for fractures when used for short-term periods.

Influenza vaccination provided a small protective effect in patients with asthma.

Moderate and severe asthma exacerbations were predictive of similar future events, and they appear to be phenotypically distinct conditions.

Nearly 7000 patients with community-acquired pneumonia were examined using updated Sepsis-3 Task Force criteria.

Comparative measures of inspiratory vs expiratory volumes show a penumbra of lung tissue at higher risk of damage from existing COPD.

Fractional exhaled nitric oxide levels directly correlated to subclinical pulmonary disease activity in children with systemic lupus erythematosus.

Medical devices such as thermometers and pacemakers are regulated differently than pharmaceuticals in the US.

Pharmaceutical research has made vast improvements in genetic studies and patient-targeted therapies.

Medicaid expansion under the American Care Act decreased uninsurance rates but patient care lacks improvement on coverage.

Patients with HIV who develop CAP do not need special treatment in comparison to healthy individuals according to a Barcelona study.

Hyperbaric oxygen therapy reduced the risk for short- and long-term mortality in patients younger than 20 who had carbon monoxide poisoning.

The TRINITY study reports the significant benefits to extafine triple therapy taken in a single inhaler compared with tiotropium in chronic obstructive pulmonary disease.

A new study found no risks for exacerbation of asthma in children given LAIV, despite ACIP recommendations against its use in children with asthma.

The inactivated monovalent influenza A(H1N1) vacccines in both adjuvanted and unadjuvanted forms were more effective in children than adults.

In the guidance documents, the FDA advised against using any marketing language that may be “misleading” or has potential to cause patient harm.

The live attenuated influenza vaccine, LAIV, is safe in children under 2 with underlying medical conditions.

Lung ultrasounds present an effective alternative to diagnosing pneumonia.